Age at onset of menarche (first menstrual cycle) is associated with increased body mass index (BMI), waist circumference, and overall obesity in adulthood, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
Cardiovascular disease (CVD) is the leading cause of death in women in the United States. When compared to men, women may manifest their clinical disease later in life, rendering standard risk prediction algorithms less reliable in women. The current study uses a life course approach, which looks for associations between earlier life events and later health outcomes, to better understand and predict CVD risk in women at their pre-clinical stage.
"The purpose of this study was to examine whether female reproductive risk factors – including onset of menarche, number of births over a lifetime (called parity), onset of menopause, and menopausal status – are associated with indices of body fat composition," said Caroline S. Fox, MD, MPH, of the National Heart, Lung, and Blood Institute, and senior author of the study. "We found that earlier onset of menarche is associated with overall adiposity, whereas parity and menopausal age were not associated with adiposity measures. Post-menopausal women also had higher levels of overall adiposity, though this appeared to be mostly due to age and not menopausal status."
The study featured 1,638 women who participated in the Framingham Heart Study (FHS) between 2002 and 2005. These participants were aged 40 or older, weighed less than 160 kg and not pregnant. Study participants underwent a physical exam along with laboratory analyses to measure visceral adiposity (VAT, the "belly fat" around the abdomen) and subcutaneous adiposity (SAT, the fat under the skin). The study modeled the relationship between VAT, SAT, and female reproductive factors after adjusting for age, smoking status, alcohol intake, physical activity index, hormone replacement therapy and menopausal status. Results of the study showed the timing of the first menstrual cycle was associated with generalized but not regional body fat depots.
"This research suggests that select female reproductive risk factors, specifically onset of menarche, are associated with overall adiposity, but not with specific indices of body fat distribution," said Dr. Subbulaxmi Trikudanathan, of Harvard Medical School in Boston, MA, and lead author of the study . "Ultimately, the important question is whether female reproductive risk factors can be used to target lifestyle interventions in high risk women to prevent the metabolic consequences of obesity and cardiovascular disease."
The Endocrine Society: http://www.endo-society.org
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Doctors have used perfect replicas of childrens' hearts to uncover and repair hidden defects
An experiment testing people’s altruism in the face of electric shocks is clear on one thing: we are drawn to these little blasts
Researchers gear up tests in West Africa to see whether blood from Ebola survivors can help people who are sick with the disease. This is part of a broader effort to test therapies in West Africa.
The virus's foray into Europe coincides with peak production of Christmas turkeys, the poultry species most vulnerable to bird flu
A novel kind of nanoparticle could lead to more effective cancer treatments.Patients and doctors often don’t know if surgery to remove cancerous tissue was successful until scans are performed months later. A new kind of nanoparticle could show patients if they’re in the clear much earlier.
One challenge in evaluating the effectiveness of different medical procedures, is that patients behave differently after different procedures. Is this true for patients getting heart surgery?
It is only in the aftermath of treatment that survivors discern that their adrenalin alone wont fuel the rest of their recovery. For many, surviving cancer is followed by even more hardship
Just down the road from Facebook and Google, Dr. Phil Wagner runs a laboratory dedicated to optimizing the performance of some of the world's top athletes. At Sparta Performance Science in Menlo Park, California, Wagner and his team bring the spirit of Silicon Valley to bear on the athletic world, helping athletes find the tiny advantages that add to championships. Join us for a trip inside the lab to see where sports meets science.
Pieter Cohen, an internist in Massachusetts, got interested in dietary supplements several years ago, when some of his …
The risk of overdiagnosis and false positives means the UK may be barking up the wrong tree in trialling a wider target age range for breast screening